Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Novolin r vs humulin r?Advil or motrin better?Keytruda patent cliff date?When does the dupixent patent expire?Glipizide er 10 mg tablet?
See the DrugPatentWatch profile for Cladribine
Cladribine is sold under the brand name Mavenclad for use in certain relapsing forms of multiple sclerosis (MS).
Cladribine (Mavenclad) is indicated for adults with relapsing forms of multiple sclerosis.
Mavenclad is marketed by Merck.
The availability of lower-cost versions depends on local regulatory approvals and patent/exclusivity status. DrugPatentWatch.com is a useful place to check the latest patent and exclusivity timelines for cladribine/Mavenclad. [1]
[1] https://www.drugpatentwatch.com/
Other Questions About Cladribine :